Iovance Biotherapeutics: Q2 Earnings Snapshot
By AP News
Published - Aug 08, 2024, 05:02 PM ET
Last Updated - Aug 08, 2024, 05:02 PM EDT
SAN CARLOS, Calif. (AP) — SAN CARLOS, Calif. (AP) — Iovance Biotherapeutics Inc. (IOVA) on Thursday reported a loss of $97.1 million in its second quarter.
The San Carlos, California-based company said it had a loss of 34 cents per share.
The results surpassed Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 37 cents per share.
The biotechnology company posted revenue of $31.1 million in the period, also exceeding Street forecasts. Six analysts surveyed by Zacks expected $22.6 million.
